1Department of Medicinal Chemistry, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran
2Department of Pharmaceutics, Faculty of pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran
3Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
4Department of Pharmacology and Toxicology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran
5Department of Pharmacology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Objective(s): Phthalimide-based derivatives have anticonvulsant activity like as phenytoin by inhibition of sodium channel. In our previously research we mentioned about some phthalimide derivatives as potent anticonvulsant agents. Materials and Methods: Fourteen analogs of 2-substituted phthalimide pharmacophore were synthesized and then were evaluated for the anticonvulsant activities in pentylenetetrazole-induced seizures (PTZ) and maximal electroshock seizure (MES) models. Results: The in vivo screening results showed that all the analogs have the ability to protect against the maximal electroshock and PTZ. The compounds 3 and 9 elevated clonic seizure thresholds at 30 min which were more active than the standard medicine phenytoin. Compounds 3, 6, 7, 11, 13 and 14 with 100% protection were the most potent ones in tonic seizure. The most potent compound in the both PTZ and MES models was compound 3. Using a model of the open pore of sodium channel, all of the compounds were docked. Results of docking showed that the ligands interacted mainly with residues II-S6 of NaV1.2 by making hydrogen bonds and have additional hydrophobic interactions with other domains in the channel's inner pore. Conclusion: Some of these compounds are more potent than phenytoin simultaneously in the clonic and tonic seizures.
3.Brodie MJ. Antiepileptic drug therapy the story so far. Seizure 2010; 19:650–655.
4.Lacoste L, Bartolucci S, Lapointey J. Pentylenetetrazole inhibits glutamate dehydrogenase and aspartate aminotransferase, and stimulates GABA aminotransferase in homogenates from rat cerebral cortex. Can J Physiol Pharmacol 1988; 66:1135–1138.
5.Wang Y, Jones PJ, Batts TW, Landry V, Patel MK, Brown ML. Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin–lidocaine pharmacophore. Bioorg Med Chem 2009; 17:7064–7072.
6.Catterall WA, Goldin AL, Waxman SG. International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57:397–409.
7.Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001; 63: 871.
8.Vamecq J, Bac P, Herrenknecht C, Maurois P, Delcourt P, Stables JP. Synthesis and anticonvulsant and neurotoxic properties of substituted N-Phenyl derivatives of the phthalimide pharmacophore. J Med Chem 2000; 43:1311-1319.
9.Małgorzata W, Katarzyna KK. Synthesis and Anticonvulsant Evaluation of Some N-Substituted Phthalimides. Acta Poloniae Pharmaceutica Drug Res 2009; 66:249-257.
10.Davood A, Shafaroodi H, Amini M, Nematollahi A, Shirazi M, Iman M. Design, Synthesis and protection against pentylenetetrazole-induced seizure of N-aryl derivatives of the phthalimide pharmacophore. Med Chem 2012; 8:953-963.
11.Davood A, Amini M, Azimidoost L, Rahmatpour S, Nikbakht A, Iman, M, et al. Docking, synthesis, and pharmacological evaluation of isoindoline derivatives as anticonvulsant agents. Med Chem Res 2013; 22:3177-3184.
12.Iman M, Saadabadi A, Davood A. Docking Studies of Phthalimide Pharmacophore as a Sodium Channel Blocker. Iran J Basic Med Sci 2013; 16:1016-1021.
13.Shafaroodi H, Moezi L, Fakhrzad A, Hassanipour M, Rezayat M, Dehpour AR. The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice. Neurosci Res 2012; 34:847-853.